Glasdegib Maleate
CAS 1416576-73-4Small Molecule
Overview
Glasdegib Maleate is a small molecule inhibitor of the Hedgehog signaling pathway used in the treatment of certain types of cancer, including acute myeloid leukemia (AML). It functions by binding to and inhibiting the Smoothened (SMO) receptor, which plays a critical role in this pathway.
Therapeutic areas
Oncology
Verified Supplier Partner
Do you supply Glasdegib Maleate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.